Baylor, Berry Genomics Team on Non-invasive Prenatal Dx | GenomeWeb

NEW YORK (GenomeWeb News) – Baylor College of Medicine said on Thursday that it will partner with the Chinese prenatal testing company Berry Genomics to combine their capabilities to improve prenatal genetic testing methods.

The partners plan to harness BCM's gene-chip microarray technologies that assess chromosome structure and Berry Genomics' technologies, which are used to evaluate fetal DNA in maternal plasma.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.